What are the prevalence rates of iron deficiency anemia across different ethnicities and genders, and what screening and treatment recommendations apply?

Iron Deficiency Prevalence by Ethnicity and Gender

Non-Hispanic Black and Mexican American women have significantly higher rates of iron deficiency than White women, with pregnant women from these ethnic groups showing prevalence rates of 2-27% for iron deficiency anemia, while the overall prevalence in pregnant women is 18.6%. 1

Prevalence Patterns by Gender

Women of Reproductive Age

• Iron deficiency anemia affects 9-12% of non-Hispanic White women and nearly 20% of Black and Mexican American women in the United States 2
• Among pregnant women specifically, 18.6% have iron deficiency, with 16.2% also having anemia based on NHANES data from 1999-2006 1
• Women with parity of 2 or more have higher prevalence rates of iron deficiency 1
• The prevalence of anemia in Black women aged 80-85 years reaches 35.6%, which is 6.4 times higher than the population average 3

Men

• Adult men have a prevalence of only 2% for iron deficiency anemia 2
• Rates of anemia in men increase monotonically with age, unlike the bimodal pattern seen in women 3
• Men should not be routinely screened but require gastrointestinal endoscopy evaluation if diagnosed with iron deficiency anemia 4

Children and Adolescents

• Children from low-income families, those living at or below poverty level, and Black or Mexican-American children are at higher risk than children from middle- or high-income families and White children 1
• The incidence in industrialized countries is 20.1% between ages 0-4 years and 5.9% between ages 5-14 years 5

Ethnic Disparities in Detail

Black Populations

• Black women have substantially higher anemia prevalence than White women across all age groups 6
• Essentially all anemia in White women is associated with iron deficiency, while a high proportion (but not all) of anemia in Black women is iron-related 6
• The compounding effect of race and age is dramatic: Black women in their 80s show prevalence rates exceeding 35% 3

Hispanic/Mexican American Populations

• Mexican American women show prevalence rates approaching 20%, similar to Black women 2
• These populations are identified as high-risk groups requiring targeted screening 3

Screening Recommendations by Population

Pregnant Women

• The USPSTF concludes that evidence for routine screening in asymptomatic pregnant women is insufficient (I statement), though screening may be warranted for other clinical reasons such as preparing for cesarean delivery 1
• The CDC recommends screening at the first prenatal visit, particularly for minority populations and those in later trimesters where rates are higher 1
• Women with hemoglobin <7.0 g/dL should be referred for further medical evaluation before labor when possible 7

Women of Childbearing Age

• Periodic screening during routine medical examinations is indicated due to the relatively high prevalence of iron deficiency (affecting up to 20% in certain ethnic groups) 1
• Heavy menstrual blood loss affects an estimated 10% of women of childbearing age, increasing iron requirements above the recommended dietary allowance 1
• Annual screening is recommended for adolescent females with risk factors including extensive menstrual blood loss or low iron intake 8

Children

• Routine screening is effective in populations at higher risk (low-income families, minority populations) where anemia is predictive of iron deficiency 1
• In populations with low prevalence (<10%), selective screening of only those with known risk factors increases the positive predictive value 1
• Screening before age 6 months is of little value for full-term infants of normal or high birthweight 1

Men and Postmenopausal Women

• Routine screening is not indicated as iron deficiency anemia is uncommon in these populations 1
• When diagnosed, gastrointestinal endoscopy evaluation is recommended, beginning with colonoscopy if the patient is older than 50 years 2

Treatment Approach by Population

Standard Oral Iron Therapy

• 60-120 mg of elemental iron daily is recommended for treatment, with hemoglobin reassessment after 4 weeks 8, 9
• Continue supplementation for 2-3 additional months after hemoglobin normalizes to replenish iron stores 8, 9
• Taking iron between meals or on an empty stomach maximizes absorption, though taking with meals is acceptable if gastrointestinal side effects occur 8

High-Risk Populations Requiring Modified Approach

• Adolescent females should receive dietary counseling alongside supplementation, with emphasis on iron-rich foods and vitamin C to enhance absorption 8
• Pregnant women require low-dose iron supplementation, though the evidence on routine supplementation's effect on maternal health and birth outcomes is insufficient 1
• Patients with rheumatoid arthritis and severe anemia may require transition to intravenous iron if oral therapy fails after 4 weeks with confirmed compliance 9

Common Pitfalls and Caveats

Diagnostic Challenges

• Determining exact prevalence rates in pregnant women is difficult due to physiologic hemodilution in later stages of pregnancy 1
• The positive predictive value of anemia screening for iron deficiency increases with increasing prevalence in the population, making screening more effective in high-risk ethnic groups 1
• In populations where anemia prevalence is low, anemia is less predictive of iron deficiency 1

Treatment Monitoring

• If hemoglobin does not increase by 1-2 g/dL after one month of treatment, consider malabsorption of oral iron, continued bleeding, or an unknown lesion 2
• Further evaluation with additional laboratory tests (MCV, RDW, serum ferritin) is needed if no response occurs after 4 weeks despite compliance 8

Screening Limitations

• The decline in childhood iron-deficiency anemia since the 1970s has decreased the effectiveness of routine anemia screening in some populations 1
• In contrast, rates among low-income pregnant women remain high with no improvement since the 1970s 1
• The prevalence of anemia and moderate-severe anemia nearly doubled from 2003-2004 to 2011-2012, raising anemia as an urgent public health issue 3